Yan Qin
Peking Union Medical College Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Yan Qin as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:26 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07540286 · A Cohort Study on the Safety and Efficacy of XH-02 in Treating HypoparathyroidismPeking Union Medical College Hospital · suspended · Hypoparathyroidism · principal investigator
- Ph1/Ph2NCT07530705 · Efficacy and Safety of Subcutaneous Injection of XH-02 in the Treatment of Adult HypoparathyroidismPeking Union Medical College Hospital · suspended · Hypoparathyroidism · principal investigator
- Ph4NCT05429515 · Effect of HFR-SUPRA in the Treatment of Multiple Myeloma-related Acute Kidney InjuryPeking Union Medical College Hospital · not yet recruiting · Multiple Myeloma, Acute Kidney Injury, Hemodiafiltration With Ultrafiltrate Regeneration (HFR) · principal investigator
- Ph2NCT05010460 · Study of Roxadustat for Reducing the Incidence of Acute Kidney Injury After Coronary Artery Bypass GraftingPeking Union Medical College Hospital · terminated · Coronary Artery Bypass · principal investigator
- Ph3NCT04745728 · Different Immunosuppressive Treatment in iMNPeking Union Medical College Hospital · recruiting · Idiopathic Membranous Nephropathy · principal investigator
- Ph3NCT04743739 · Rituximab Combined With Cyclosporine Versus Rituximab Alone in the Treatment of iMNPeking Union Medical College Hospital · terminated · Idiopathic Membranous Nephropathy · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:26 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 3 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 23:26 UTC. The ranking covers the 200 most relevant of 276 PubMed records, and a shared surname and initials can bring in a namesake. All 276 on PubMed
- Sintilimab plus a bevacizumab biosimilar (IBI305) versus sorafenib in unresectable hepatocellular carcinoma (ORIENT-32): a randomised, open-label, phase 2-3 study.Lancet Oncol · 20211,003 citationsRCR 54.5
- 593 citationsRCR 30.9
- Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial interim results.Nat Med · 2022547 citationsRCR 35.5
- An integrated theory of the mind.Psychol Rev · 2004494 citationsRCR 13.6
- Toripalimab plus chemotherapy in treatment-naïve, advanced esophageal squamous cell carcinoma (JUPITER-06): A multi-center phase 3 trial.Cancer Cell · 2022462 citationsRCR 28.6
- Loncastuximab tesirine in relapsed or refractory diffuse large B-cell lymphoma (LOTIS-2): a multicentre, open-label, single-arm, phase 2 trial.Lancet Oncol · 2021404 citationsRCR 22.1
- Frozen versus fresh single blastocyst transfer in ovulatory women: a multicentre, randomised controlled trial.Lancet · 2019395 citationsRCR 25.3
- 392 citationsRCR 33.0
- Live Birth with or without Preimplantation Genetic Testing for Aneuploidy.N Engl J Med · 2021280 citationsRCR 21.8
- Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: a randomized controlled trial.Dig Liver Dis · 2015250 citationsRCR 10.4